Purity Claims
'99% purity' and similar claims are ubiquitous in research peptide marketing. This page explains what purity testing actually measures, what it cannot verify, and why purity claims are insufficient to establish product identity or safety.
Analytical chemistry context is provided for educational purposes. TryTrutide does not evaluate vendor claims.
Common Claims — Fact-Checked
These claims appear frequently in community discussions. Each is evaluated against the best available clinical evidence.
"99% purity means the product is safe."
✗UnsupportedPurity and safety are different properties. A product can be 99% pure and still be the wrong compound, contain a dangerous 1% impurity, or be unsafe for human use at the stated dose. Purity testing does not establish safety.
"Higher purity means better results."
?Context NeededIf the product is correctly identified as retatrutide, higher purity reduces impurity exposure. However, purity testing without identity confirmation does not establish that the product is retatrutide at all.
Evidence Summary
HPLC purity testing: measures the area under the main chromatographic peak as a percentage of total peak area. Does not identify the compound. Does not screen for all impurities. Does not establish safety. Identity confirmation requires mass spectrometry with a reference standard — a test rarely performed by research peptide vendors.
Analyzed Threads
These threads were selected for editorial analysis. TryTrutide does not link to Reddit posts.
"Which research peptide supplier has the best retatrutide?"
✗UnsupportedClaim: Community members regularly share and rank grey-market peptide suppliers offering retatrutide, claiming some suppliers have "pharmaceutical grade" product verified by third-party testing.
Retatrutide has not received FDA approval as of September 2026. No commercial pharmaceutical-grade retatrutide exists outside of clinical trial supply. Products sold by research peptide suppliers are not manufactured under FDA cGMP conditions, have not been evaluated for sterility, potency, or purity by any regulatory body, and cannot legally be sold for human use. Third-party certificates of analysis (COAs) from peptide suppliers test for molecular identity (typically by HPLC or mass spec) but do not assess sterility, endotoxin levels, or the presence of process impurities that could cause serious adverse events. The FDA has issued warning letters to suppliers of similar unapproved peptides.
Reddit Observatory
26 topic categories — community claims vs. clinical evidence
Want a Physician to Review Your Eligibility?
Retatrutide is not yet FDA approved. A physician can review your health profile and discuss investigational access options.
Start Physician Review